May be taken with or without food. May be taken w/ meals to reduce GI discomfort.
Administration
May be taken with or without food. May be taken w/ meals to reduce GI discomfort.
|
Contraindications
Angle-closure glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, symptomatic prostatic hypertrophy, bladder neck obstruction or predisposition to urinary retention. Patient undergoing treatment for acute asthmatic attack. Newborn or premature infants; elderly and debilitated patients. Lactation. Concomitant use with MAOIs.
|
Special Precautions
Patient with CV disease, including hypertension and ischaemic heart disease; thyroid dysfunction (e.g. hyperthyroidism), history of bronchial asthma, other chronic breathing disorders; increased intraocular pressure, acute porphyria. Hepatic impairment. Children (≥2 years). Pregnancy. Patient Counselling This drug may cause dizziness, drowsiness, or sedation; if affected, do not drive or operate machinery. Monitoring Parameters Monitor weight periodically; excess anticholinergic effects at the start of treatment and periodically thereafter.
|
Adverse Reactions
Significant: CNS depression (e.g. dizziness, sedation), hypotension; excitation (in children).
Blood and lymphatic system disorders: Rarely, blood dyscrasias in prolonged use (e.g. leucopenia, haemolytic anaemia, agranulocytosis, thrombocytopenia).
Cardiac disorders: Palpitation, extrasystoles, tachycardia.
Ear and labyrinth disorders: Tinnitus, vertigo, acute labyrinthitis.
Eye disorders: Blurred vision, diplopia.
Gastrointestinal disorders: Dry mouth, nausea, vomiting, diarrhoea, constipation, epigastric distress.
General disorders and administration site conditions: Fatigue, rigors.
Hepatobiliary disorders: Jaundice, hepatitis, cholestasis, hepatic failure.
Immune system disorders: Allergic reactions (e.g. rash, oedema), anaphylactic shock.
Investigations: Weight gain, abnormal hepatic function.
Metabolism and nutrition disorders: Increased appetite, anorexia.
Nervous system disorders: Drowsiness, headache, tremor, restlessness, paraesthesia, convulsion, disturbed coordination, neuritis.
Psychiatric disorders: Confusion, insomnia, nervousness, hallucination, euphoria, irritability, aggressive behaviour, hysteria.
Renal and urinary disorders: Urinary retention, frequency or difficulty in micturition.
Reproductive system and breast disorders: Early menses.
Respiratory, thoracic and mediastinal disorders: Dry nose and throat, chest tightness and wheezing, nasal stuffiness, epistaxis, thickened bronchial secretion.
Skin and subcutaneous tissue disorders: Photosensitivity, urticaria, increased sweating.
|
Drug Interactions
Additive effects with other CNS depressants (e.g. sedatives, hypnotics, tranquillisers, antianxiety drugs). May interfere with serotonin-enhancing antidepressants (e.g. SSRI) which may result in recurrence of depression and related symptoms.
|
ATC Classification
R06AX02 - cyproheptadine ; Belongs to the class of other antihistamines for systemic use.
|